Victor G. Vogel, MD, MHS, FACP is the Director of the Cancer Service Line of the Geisinger Health System. Prior to his current appointment, Dr. Vogel served as the National Vice President for Research at the American Cancer Society.
Dr. Vogel was previously Professor of Medicine and Epidemiology at the University of Pittsburgh School of Medicine from, and Co-Director of the Magee-Womens Hospital/University of Pittsburgh Cancer Institute Biochemoprevention Program. He served as the National Protocol Chairman of the National Cancer Institutes STAR Trial (Study of Tamoxifen and Raloxifene), and serves on the Board of Directors of the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical cooperative group.
Dr. Vogel is the author of more than 250 articles, book chapters, and abstracts. He edited the books Management of Patients at High Risk for Breast Cancer and Handbook of Breast Cancer Risk Assessment: Evidence-Based Guidelines for Evaluation, Prevention, Counseling, and Treatment.